Biological imaging and the molecular basis of dopaminergic diseases (Q40885490)

24 September 2017

1 reference

title

Biological imaging and the molecular basis of dopaminergic diseases (English)

1 reference

24 September 2017

1 reference

Barrio JR

1

1 reference

24 September 2017

Huang SC

series ordinal

2

1 reference

24 September 2017

Phelps ME

series ordinal

3

1 reference

24 September 2017

language of work or name

English

0 references

publication date

1 August 1997

1 reference

24 September 2017

Biochemical Pharmacology

1 reference

24 September 2017

54

1 reference

24 September 2017

3

1 reference

24 September 2017

341-348

1 reference

Striatal dopamine deficiency in Parkinson's disease: role of aging

24 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900031-2

Dopamine receptors and transporters in Parkinson's disease and schizophrenia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900031-2

Cellular and molecular mechanisms of drug dependence

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900031-2

Midbrain dopaminergic cell loss in Parkinson's disease: computer visualization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900031-2

Chronic administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine to monkeys: behavioural, morphological and biochemical correlates.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900031-2

Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900031-2

The role of environmental toxins in the etiology of Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900031-2

Mild parkinsonism in persons exposed to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900031-2

Markers of dopamine metabolism in Parkinson's disease. The Parkinson Study Group.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900031-2

The next frontier in Parkinson's disease: presymptomatic detection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900031-2

Recovery from experimental parkinsonism in primates with GM1 ganglioside treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900031-2

Approaches to the design of biochemical probes for positron emission tomography

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900031-2

Dopamine visualized in the basal ganglia of living man.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900031-2

Central dopaminergic pathways in hemiparkinsonism examined by positron emission tomography

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900031-2

Positron emission tomography after MPTP: observations relating to the cause of Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900031-2

Striatal dopamine distribution in parkinsonian patients during life.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900031-2

[18F]fluoro-L-dopa for the in vivo study of intracerebral dopamine.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900031-2

Nigrostriatal function in humans studied with positron emission tomography

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900031-2

PET studies of parkinsonian patients treated with autologous adrenal implants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900031-2

Unilateral MPTP lesion in a rhesus monkey: effects on the striatal dopaminergic system measured in vivo with PET using various novel tracers.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900031-2

Transplantation of human fetal dopamine cells for Parkinson's disease. Results at 1 year

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900031-2

Grafts of fetal dopamine neurons survive and improve motor function in Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900031-2

The metabolism of [18F]6-fluoro-L-3,4-dihydroxyphenylalanine in the hooded rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900031-2

The effects of carbidopa on the metabolism of 6-[18F]fluoro-L-dopa in rats, monkeys and humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900031-2

Comparative in vivo metabolism of 6-[18F]fluoro-L-dopa and [3H]L-dopa in rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900031-2

L-6-[18F]fluoro-dopa metabolism in monkeys and humans: biochemical parameters for the formulation of tracer kinetic models with positron emission tomography.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900031-2

6-[18F]fluoro-L-dopa metabolism in MPTP-treated monkeys: assessment of tracer methodologies for positron emission tomography

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900031-2

6-18F-L-dopa imaging of the dopamine neostriatal system in normal and clinically normal MPTP-treated rhesus monkeys

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900031-2

Cerebral metabolism of 6-[18F]fluoro-L-3,4-dihydroxyphenylalanine in the primate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900031-2

Striatal dopamine metabolism in living monkeys examined by positron emission tomography.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900031-2

Determination of plasma [18F]-6-fluorodopa during positron emission tomography: elimination and metabolism in carbidopa treated subjects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900031-2

Brain dopamine metabolism in patients with Parkinson's disease measured with positron emission tomography

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900031-2

Inhibition of L-[18F]fluorodopa uptake into human brain by amino acids demonstrated by positron emission tomography

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900031-2

Graphical evaluation of blood-to-brain transfer constants from multiple-time uptake data

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900031-2

Striatal kinetics of [11C]-(+)-nomifensine and 6-[18F]fluoro-L-dopa in Parkinson's disease measured with positron emission tomography.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900031-2

Blood-brain transfer and metabolism of 6-[18F]fluoro-L-dopa in rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900031-2

Preparation and properties of a homogeneous aromatic l-amino acid decarboxylase from hog kidney

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900031-2

Kinetics and modeling of L-6-[18F]fluoro-dopa in human positron emission tomographic studies.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900031-2

Effects of decarboxylase inhibition on the biosynthesis of brain monoamines.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900031-2

L-dihydroxyphenylalanine and its decarboxylase: new ideas on their neuroregulatory roles.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900031-2

In vivo voltammetric determination of the kinetics of dopamine metabolism in the rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900031-2

Dynamics of the striatal 3-MT pool in rat and mouse: species differences as assessed by steady-state measurements and intracerebral dialysis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900031-2

Changes in specific activity of dopamine metabolites as evidence of a multiple compartmentation of dopamine in striatal neurons.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900031-2

Aromatic L-amino acid decarboxylase is modulated by D1 dopamine receptors in rat retina

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900031-2

Aromatic L-amino acid decarboxylase activity of the rat retina is modulated in vivo by environmental light

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900031-2

Modulation of retinal aromatic L-amino acid decarboxylase via alpha 2 adrenoceptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900031-2

6-[18F]fluoro-L-dopa probes dopamine turnover rates in central dopaminergic structures.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900031-2

Partial lesions of the dopaminergic nigrostriatal system in rat brain: biochemical characterization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900031-2

Turnover of dopamine and dopamine metabolites in rat brain: comparison between striatum and substantia nigra

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900031-2

Occurrence and distribution of aromatic L-amino acid (L-DOPA) decarboxylase in the human brain.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900031-2

Isolation and characterization of a cDNA clone encoding human aromatic L-amino acid decarboxylase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900031-2

Brain uptake of radiolabeled amino acids, amines, and hexoses after arterial injection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900031-2

Synthetic amino acids and the nature of L-DOPA transport at the blood-brain barrier

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900031-2

Barrier mechanisms for neurotransmitter monoamines and their precursors at the blood-brain interface

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900031-2

Functional heterogeneity of the cerebrovascular endothelium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900031-2

Transport of gabapentin, a gamma-amino acid drug, by system l alpha-amino acid transporters: a comparative study in astrocytes, synaptosomes, and CHO cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900031-2

Rapid remodeling of axonal arbors in the visual cortex

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900031-2

Synaptic reorganization in the hippocampus induced by abnormal functional activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900031-2

Positron emission tomographic imaging of the dopamine transporter with 11C-WIN 35,428 reveals marked declines in mild Parkinson's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900031-2

Striatal 18F-dopa uptake: absence of an aging effect

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900031-2

The nigrostriatal dopaminergic system assessed in vivo by positron emission tomography in healthy volunteer subjects and patients with Parkinson's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900031-2

Asymptomatic striatal dopamine depletion: PET scans in unilateral MPTP monkeys.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900031-2

Correlation of striatal fluorodopa uptake in the MPTP monkey with dopaminergic indices

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900031-2

Human positron emission tomographic [18F]fluorodopa studies correlate with dopamine cell counts and levels

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900031-2

Radiofluorinated L-m-tyrosines: new in-vivo probes for central dopamine biochemistry.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900031-2

Radioligands of the vesicular monoamine transporter and their use as markers of monoamine storage vesicles

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900031-2

Brain kinetics of L-[?-11 C]DOPA in humans studied by positron emission tomography

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900031-2

Glucose transporter proteins in brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900031-2

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0006-2952(97)00031-2

1 reference

24 September 2017

1 reference